Status:
UNKNOWN
DAA Therapy in Pediatric Patients With Chronic Hepatitis C
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Collaborating Sponsors:
Directorate of Health and Family Welfare, Punjab
Conditions:
Chronic Hepatitis c
Eligibility:
All Genders
12-18 years
Phase:
NA
Brief Summary
The Mukh-Mantri Punjab Hepatitis C Relief Fund (MMPHCRF) is a public health initiative for prevention and control of hepatitis C in the Punjab state, India. The efficacy of decentralised public health...
Detailed Description
Consecutive chronic hepatitis C (HCV) infected children \[age: ≥12 to \<18 years; both treatment-naïve (TN) and treatment-experienced, (TE)\] are being enrolled. Genotyping is not recommended for non...
Eligibility Criteria
Inclusion
- Chronic hepatitis C, all genotypes
- Ages eligible for study: ≥12 to \<18 years (Child)
- Gender eligible for study: either
- Treatment-naive or treatment-experienced: either
Exclusion
- Chronic liver disease of a non-HCV etiology
- serum creatinine \>1.5 mg/dL
- Evidence of hepatocellular carcinoma or other malignancy
- Co-infection with hepatitis B virus, or HIV
- Significant cardiovascular, pulmonary, or neurological disease
- Evidence of a malabsorption syndrome that could interfere with absorption of orally administered medications
- History of solid organ or bone marrow transplantation.
Key Trial Info
Start Date :
June 18 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03481036
Start Date
June 18 2016
End Date
December 31 2020
Last Update
June 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Post Graduate Institute of Medical Education and Research
Chandigarh, India, 160012